Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-07

Clinical Trial Update: Enhancing Week-long Psychological Treatment for PTSD With Ketamine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Yale University is evaluating whether ketamine augmentation can improve outcomes of a week-long psychological treatment for posttr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: RECRUITING